4//SEC Filing
APPLE ROBERT F 4
Accession 0001016169-22-000035
CIK 0001016169other
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 6:38 PM ET
Size
6.9 KB
Accession
0001016169-22-000035
Insider Transaction Report
Form 4
APPLE ROBERT F
Executive Vice President & CFO
Transactions
- Award
Common Stock
2022-03-03+86,814→ 2,526,055 total - Tax Payment
Common Stock
2022-03-03$3.80/sh−37,695$143,241→ 2,488,360 total
Footnotes (1)
- [F1]On June 13, 2019, Mr. Apple was granted a performance stock unit award that was contingent upon achieving certain performance goals over the three-year performance period ended December 31, 2021. The number of shares acquired represent the total number of shares earned upon achievement of one of the performance goals, which was certified and vested on March 3, 2022. The shares of common stock disposed represents the number of shares withheld by the company to settle tax liabilities in connection with the vesting of the performance stock unit award and were not actually sold.
Documents
Issuer
ANTARES PHARMA, INC.
CIK 0001016169
Entity typeother
Related Parties
1- filerCIK 0001054942
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 6:38 PM ET
- Size
- 6.9 KB